Mr. Willie A. Deese is Independent Director of Dentsply International Inc since February 2011. Mr. Deese has served as Executive Vice President at Merck & Co., Inc., since 2008 and President of the Merck Manufacturing Division since 2005
Deese originally joined Merck in 2004 as the company?s Senior Vice President of Global Procurement. Previously, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Vice President of Purchasing, at Kaiser Permanente.
Management Efficency
The company has return on total asset (ROA) of 5.18 % which means that it generated profit of $5.18 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.61 % meaning that it created $15.61 on every $100 dollars invested by stockholders.
The company currently holds 1.69 B in liabilities with Debt to Equity (D/E) ratio of 0.75 which is about average as compared to similar companies. DENTSPLY International Inc has Current Ratio of 1.38 which is within standard range for the sector.
DENTSPLY International Inc. designs, develops, manufactures, and markets a range of consumable dental solutions for the professional dental market worldwide. DENTSPLY International Inc [XRAY] is traded on NASDAQ in USA. It is located in York, PA and employs 11,900 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory